FROOME CLOSE
Medical Technologies
Drug Calculator
Health Economics
Drug AE
Drug Label
Drug Sync
← Main site
Health Economics — Froome Close
← Health Economics
Glioblastoma
Select a treatment setting
Adjuvant
Adjuvant therapy
Regimens
1
With dosing
0
›
Adjuvant therapy elderly or poor performance status patients
Regimens
3
With dosing
3
›
Adjuvant therapy standard patients
Regimens
6
With dosing
6
›
Adjuvant therapy, elderly or poor performance status patients
Regimens
1
With dosing
0
›
Adjuvant therapy, standard patients
Regimens
2
With dosing
2
›
First-line/Induction
First-line therapy
Regimens
1
With dosing
0
›
First-line therapy elderly or poor performance status patients
Regimens
3
With dosing
3
›
First-line therapy standard patients
Regimens
8
With dosing
8
›
Maintenance
Maintenance after first-line therapy
Regimens
3
With dosing
3
›
Other
Recurrent disease non-curative therapy
Regimens
1
With dosing
0
›
Recurrent disease non-curative therapy non-randomized or retrospective data
Regimens
7
With dosing
7
›
Recurrent disease non-curative therapy randomized data
Regimens
9
With dosing
9
›